HER back pain was so debilitating she couldn’t sleep and had to crawl to the bathroom. Even more frighteningly, she was ...

Mec-V demonstrates median OS of 21.5 months in patients with treatment-refractory leiomyosarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma compared with approximately 12 months with ...

Ewing sarcoma is a rare and aggressive type of bone and soft tissue cancer. The tumor was on Eliy's scapula and was ...

Eliy Simmer is a cancer survivor and advocate for pediatric cancer warriors and their families who is now working hard to ...

Lucknow: Children suffering from serious bone cancers will now receive complete treatment — from chemotherapy to complex limb ...

Gratitude and resilience are central themes, emphasizing the importance of appreciating life's basics and community support ...

OS Animal Health may soon stand on its own. A subsidiary of OS Therapeutics—a company known for Listeria -based oncology ...

The phase 2 ChonDRAgon study compared ozekibart to placebo in patients with metastatic or unresectable conventional chondrosarcoma who been diagnosed with radiographic progression.

Patients with advanced osteosarcoma often experience severe pain that significantly impacts their quality of life, making pain management and comfort care crucial. This study aims to explore key ...

The global soft tissue sarcoma market is poised for substantial growth from 2024 to 2035, driven by the rising prevalence of this rare, aggressive cancer affecting connective tissues. Key growth ...

Ewing sarcoma is a rare but increasing concern in pediatric oncology, defined by the EWSR1-FLI1 fusion gene. Primarily affecting individuals aged 10-20, it manifests in bones and soft tissue, often ...

Berenson Cancer Center published survival data analyzed by the Institute for Myeloma & Bone Cancer Research of 175 consecutive and unselected patients with multiple myeloma in the ...